Device Trial Radar · NCT05988645
Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Aug 1, 2023
Primary completion
Nov 29, 2026
Study completion Nov 29, 2026
Sponsor
- Lead sponsor
- MiWEndo Solutions S.L.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 14, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study involves the planned use of a new microwave-based device during colonoscopy procedures in 50 patients to assess the performance and safety of its use for detection of colorectal polyps and lack of normal clinical practice modification. The device is a final design version, which has been previously tested in several preclinical studies (including phantom studies, an ex vivo study with human tissues, and an in vivo study with porcine model) and in a pilot study in humans (NCT05477836)
Conditions
- Colorectal Cancer
- Colorectal Polyp
- Colorectal Adenoma
- Colorectal Adenomatous Polyp
- Colorectal Adenocarcinoma
- Colorectal Neoplasms
Interventions
MiWEndo SystemDevice
All colonoscopies will be performed with high-definition technology. The MiWEndo System will be fitted to the tip of the endoscope before colonoscopy is started and connected to the microwave processor unit. Endoscopies will be performed by experienced endoscopists who will be previously trained on the use of the MiWEndo System. The MiWEndo Analyzer will be managed by the assistant. At the beginning of the extubation, the MiWEndo System will be turned on and the endoscopist will put music headphones on (blind to the results of MiWEndo). In case one of them identifies a polyp, the exploration will be stopped and check if it has been detected by the alternative method as well. All the polyps will be resected and sent to the Pathological Department for histological analysis following the usual clinical practice. A stopwatch will be used to measure both total procedure time and withdrawal time.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of polypsTime frame: During the procedure.
- Number of adverse events.Time frame: During the procedure and up to 2 weeks after.
- Number of mural injuries.Time frame: During the procedure and up to 2 weeks after.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Clinic
Barcelona, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.